Capitalisation of R&D costs can improve a company's short-term financial performance by reducing immediate expense recognition, potentially increasing earnings. However, these costs will need to be amortised over time, impacting future earnings. Expensing R&D costs hits short-term earnings, but avoids future amortisation. Both methods affect a company's profit margins and earnings per share.